1mg

Molecular Formula : C19 D4 H12 O3

Molecular Formula : C13C3H9N3O2

Molecular Formula : C4 2H3 H4 N3 O

Molecular Formula : C23H9D5Na2O11

Molecular Formula : C7H5D9ClNO2

C-reactive protein (CRP) is synthesized in the liver by macrophage. Its level in blood increases when inflammation occurs. CRP serves as a useful marker for diagnosis of inflammation. High-sensitivity C-reactive protein (hsCRP), can serve as a risk marker for the diagnosis of myocardial infarction, ischemic stroke, peripheral vascular disease. Measuring hsCRP in blood is helpful to provide positive treatment of the disease.

C-reactive protein (CRP) is synthesized in the liver by macrophage. Its level in blood increases when inflammation occurs. CRP serves as a useful marker for diagnosis of inflammation. High-sensitivity C-reactive protein (hsCRP), can serve as a risk marker for the diagnosis of myocardial infarction, ischemic stroke, peripheral vascular disease. Measuring hsCRP in blood is helpful to provide positive treatment of the disease.

Cytotoxic T lymphocyte-associated molecule-4 (CTLA-4) is a cell surface molecule that is closely related to CD28, and a powerful negative regulator of T cell activation. Structurally, CTLA-4 is a member of the Ig superfamily, having a single extracellular V-like domain , homology with CD28; The overall sequence homology between CD28 and CTLA-4 is about 20%, but they share a 27% (murine) to 31% (human) identity at the amino acid level. Inhibitory receptor acting as a major negative regulator of T-cell responses. The affinity of CTLA-4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory coreceptor CD28.

CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4) is also known as CD152, is an Inhibitory receptor acting as a major negative regulator of T-cell responses. CTLA-4 is a member of the immunoglobulin superfamily, which is expressed on the surface of T cells and transmits an inhibitory signal to T cells. CTLA-4 and CD28 are homologous receptors expressed by both CD4+ and CD8+ T cells, which mediate opposing functions in T-cell activation. Both receptors share a pair of ligands expressed on the surface of antigen-presenting cells (APCs). The affinity of CTLA-4 for its natural B7 family ligands, CD80 and CD86, is considerably stronger than the affinity of their cognate stimulatory co-receptor CD28.

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI).

Cardiac TnT (cTnT) is the largest subunit of the troponin complex which is composed of cTnT, troponin I (TnI), troponin C (TnC). It is encoded by the TNNT2 gene with a calculated molecular weight of 34.6 kDa. The cTnT is considered as a useful biomarker for the diagnosis of acute myocardial infarction.

Cardiac TnT (cTnT) is the largest subunit of the troponin complex which is composed of cTnT, troponin I (TnI), troponin C (TnC). It is encoded by the TNNT2 gene with a calculated molecular weight of 34.6 kDa. The cTnT is considered as a useful biomarker for the diagnosis of acute myocardial infarction.

Molecular Formula : C32 H46 O8

Molecular Formula : C32 H44 O8

Molecular Formula : C27H28O12 • x(Na)

Molecular Formula : C27H25D3O12 • x(Na)

Molecular Formula : C37H48D6NNaO9S

Molecular Formula : C12H14O5

Molecular Formula : C13 D6 H18 N2 O

Molecular Formula : C34 H60 N3 O6 . Cl

CXCL10 also known as IP-10 is belonging to the CXC chemokine family. It is encoded by the CXCL10 gene, and in murine it is also named the CRG-2 gene. The gene was originally identified as an immediate early gene induced in response to macrophage activation. This chemokine elicits its effects by binding to the cell surface chemokine receptor CXCR3. CXCL10 has been shown to be a chemoattractant for activated T-lymphocytes and monocytes/macrophages. It also has other roles, such as promotion of T cell adhesion to endothelial cells, and inhibition of bone marrow colony formation and angiogenesis. Murine CXCL10 shares approximately 67 % amino acid sequence identity with human CXCL10.

CXCL11 also known as I-TAC is belonging to the CXC chemokine family and shares 36 % and 37 % amino acid sequence homology with IP-10 and MIG, respectively. It is highly expressed in peripheral blood leukocytes, pancreas and liver. Expression of CXCL11 is strongly induced by IFN-γ and IFN-β, and weakly induced by IFN-α. This chemokine elicits its effects by binding to the cell surface chemokine receptor CXCR3, which with a higher affinity than do the other chemokines for this receptor, CXCL9 and CXCL10. Similar to CXCL10, CXCL11 has been shown to be a chemoattractant for IL-2-activated T-lymphocytes, but not for isolated T-cells, neutrophils or monocytes.

Molecular Formula : C33 H40 N2 O8 S2 . x C6 H15 N

Molecular Formula : C19H15D6N3S

Molecular Formula : C9 2H5 H8 Cl N6

Molecular Formula : C21 H21 O11 . Cl

Molecular Formula : C27 H31 O15 . Cl

Molecular Formula : C20 H19 O10 . Cl

Molecular Formula : C15 H11 O6 . Cl

Molecular Formula : C21 H21 O11 . Cl

Molecular Formula : C37 H43 N3 O10 S2

Molecular Formula : C63 H87 Co N13 O15 P

Molecular Formula : C8 H8 Cl2 O2

Molecular Formula : C64 H90 Co N14 O14 P

Molecular Formula : C2 H4 15N4

Molecular Formula : C6 D11 H2 N O3 S

Molecular Formula : C30 H50 O

Molecular Formula : C20 2H3 H18 N . Cl H

Molecular Formula : C11H11D4Cl2N5

Molecular Formula : C27 H41 N O2

Molecular Formula : C60 H60 O20

Molecular Formula : C7 2H4 H11 Cl2 N2 O2 P

Molecular Formula : C20 H20 N2 O3

Molecular Formula : C23 H28 N2 O . H Cl

Molecular Formula : C62¹³C2H109D4N11O13

Molecular Formula : C62H107D4N11O12